Jong Hoon Yeom

Jong Hoon Yeom

Auto-generated profile, based on publicly available information

Jong Hoon Yeom

Department of Anesthesiology, Hanyang University Guri Hospital, Hanyang University School of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Korean Journal of Anesthesiology
Verified
Journal Article
Open access
PDF file
JRJae Hyung Ryu
Jae Hyung Ryu
JSJae Hang Shim
Jae Hang Shim
JYJong Hoon Yeom
Jong Hoon Yeom
WSWoon Geon Shin
Woon Geon Shin
SCSangyun Cho
Sangyun Cho
WJWoo Jae Jeon
Woo Jae Jeon
Background: Ultrasound-guided greater occipital nerve (GON) block has been frequently used to treat various types of headaches, and botulinum toxin has recently begun to be used in patients with headache. Our study presents the longterm effect of botulinum toxin on GON block using ultrasound in patients with chronic headache in occipital area. Methods: Patients with occipital headache were divided into two groups (bupivacaine: BUP group [n = 27], botulinum toxin: BTX group [n = 27]), and ultrasound-guided GON block was performed at the C2 level. GON was detected with ultrasound and distance from GON to midline, from the skin surface to GON, and size of GON were measured in both groups. Visual analogue scale (VAS) scores and Likert scale were assessed at pretreatment and at 1, 4, 8, and 24 weeks after treatment in both groups. Results: The distance from GON to midline was 18.9 ± 4.4 mm (right) and 17.3 ± 3.8 mm (left). The depth from the skin was 12.9 ± 1.5 mm (right) and 13.4 ± 1.6 mm (left). GON size was 3.1 mm on both sides. The VAS score and patient satisfaction score (Likert scale) in 4, 8, and 24 weeks after injection were superior for the BTX than the BUP group. Conclusions: Ultrasound-guided GON block using BTX is effective in reducing short-term and long-term pain in patients with chronic headache in the occipital area.

1 January 2012 in Korean Journal of Anesthesiology
Verified
Journal Article
Open access
PDF file
JYJong Hoon Yeom
Jong Hoon Yeom
KKKyoung Hun Kim
Kyoung Hun Kim
MCMyong-Su Chon
Myong-Su Chon
JBJangwon Byun
Jangwon Byun
SCSang Yun Cho
Sang Yun Cho
Although acute tolerance to opioids, especially to remifentanil, has been demonstrated consistently in animal studies, the results of clinical trials in humans are controversial. The aim of this study was to determine whether intraoperative infusions of remifentanil used as an adjuvant in general anesthesia result in acute tolerance, an event manifested by increased postoperative pain and a higher opioid requirement than usual. Sixty patients who underwent surgery under general anesthesia for spinal fusion were randomly assigned to receive sevoflurane-nitrous oxide-oxygen (group SO, n = 20), sevoflurane-remifentanil-nitrous oxide-oxygen (group SR, n = 20), or propofol-remifentanil-oxygen (group PR, n = 20) in a double-blinded manner. All patients within 1 hour after induction received PCA (fentanyl 0.4 µg/kg/ml and ondansetron 16 mg) administered intravenously at a basal infusion rate of 1 ml/h, after being intravenously injected with a loading dose of fentanyl (1 µg/kg). Data for fentanyl requirement, verbal Numerical Rating Scale (NRS) pain score at rest, and presence of nausea or vomiting were collected at 1, 24, and 48 hours after surgery. We did not find any significant difference in postoperative PCA fentanyl requirements, NRS or side effects among the groups. Remifentanil as an adjuvant to sevoflurane or propofol in general anesthesia for adults having surgery for spinal fusion does not appear to cause acute opioid tolerance or hyperalgesia in patients. However, further studies are needed to elucidate whether sevoflurane and propofol exert a clinically significant effect on opioid-induced tolerance or hyperalgesia and whether this effect is related to the age of the patient, the dose and duration of remifentanil given and the intensity of pain experienced postoperatively.

1 January 2012 in Korean Journal of Anesthesiology
Verified
Journal Article
Open access
PDF file
JYJong Hoon Yeom
Jong Hoon Yeom
MCMyong-Su Chon
Myong-Su Chon
WJWoo Jae Jeon
Woo Jae Jeon
JSJae-Hang Shim
Jae-Hang Shim
In this study, we assessed the effectiveness of ketamine as an alternative to non-steroidal anti-inflammatory drugs (NSAID), to manage acute postoperative pain after spinal fusion when given intravenously via a patient-controlled analgesia (PCA) pump in which the dose was proportional to that of fentanyl. Forty patients undergoing 1-2 level spinal fusion were enrolled in this study. Patients were intraoperatively randomized into two groups to receive intravenous PCA consisting either of fentanyl 0.4 µg/ml/kg (control group) or fentanyl 0.4 µg/ml/kg with ketamine 30 µg/ml/kg (ketamine group) after intravenous injection of a loading dose. The loading dose in the control group was fentanyl 1 µg/kg with normal saline equal to ketamine volume and in the ketamine group it was fentanyl 1 µg/kg with ketamine 0.2 mg/kg. The verbal numerical rating scale (NRS), fentanyl and ketamine infusion rate, and side effects were evaluated at 1, 24, and 48 hours after surgery. There were no significant differences in patient demographics, duration of surgery and anesthesia or intra-operative opioids administration. We did not find any significant differences in the mean infusion rate of intraoperative remifentanil or postoperative fentanyl or in the side effects between the groups, but we did find a significant difference in the NRS between the groups. Based on our results, we conclude that a small dose of ketamine (0.5-2.5 µg/kg/min) proportional to fentanyl is not only safe, but also lowers postoperative pain intensity in patients undergoing spinal fusion, although the opioid-sparing effects of ketamine were not demonstrated.

1 January 2023 in Annals of Surgical Treatment and Research
Verified
Journal Article
Open access
PDF file
HKHyung Suk Kim
Hyung Suk Kim
HKHyun Il Kim
Hyun Il Kim
YYYoung Joon Yoon
Young Joon Yoon
JYJong Hoon Yeom
Jong Hoon Yeom
MKMin Gyu Kim
Min Gyu Kim
Kim HS, et al. Ann Surg Treat Res. 2023 Oct;105(4):198-206. https://doi.org/10.4174/astr.2023.105.4.198

31 July 2016 in Anesthesia and Pain Medicine
Verified
Journal Article
Open access
JYJong Hoon Yeom
Jong Hoon Yeom
MOMi Kyung Oh
Mi Kyung Oh
DADae-Woong Ahn
Dae-Woong Ahn
SPSoo In Park
Soo In Park

1 January 2020 in Journal of Gastric Cancer
Verified
Journal Article
Open access
PDF file
WCWon Yong Choi
Won Yong Choi
HKHyun Il Kim
Hyun Il Kim
SPSeong Ho Park
Seong Ho Park
JYJong Hoon Yeom
Jong Hoon Yeom
WJWoo Jae Jeon
Woo Jae Jeon
MKMin Gyu Kim
Min Gyu Kim
Choi WY, et al. J Gastric Cancer. 2020 Dec;20(4):421-430. https://doi.org/10.5230/jgc.2020.20.e34